These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19548003)

  • 1. Toxoplasma gondii: host-parasite interaction and behavior manipulation.
    da Silva RC; Langoni H
    Parasitol Res; 2009 Oct; 105(4):893-8. PubMed ID: 19548003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.
    Blader IJ; Saeij JP
    APMIS; 2009 May; 117(5-6):458-76. PubMed ID: 19400868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Toxoplasma gondii persistence and latency.
    Sullivan WJ; Jeffers V
    FEMS Microbiol Rev; 2012 May; 36(3):717-33. PubMed ID: 22091606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis: comparative species susceptibility and host immune response.
    Innes EA
    Comp Immunol Microbiol Infect Dis; 1997 Feb; 20(2):131-8. PubMed ID: 9208198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Immunological Response and Pathobiology of Mice Inoculated with Toxoplasma gondii Isolated from Different Hosts.
    Yang Y; Ren H; Xin S; Jiang N
    J Parasitol; 2021 Mar; 107(2):179-181. PubMed ID: 33662116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.
    Pittman KJ; Knoll LJ
    Microbiol Mol Biol Rev; 2015 Dec; 79(4):387-401. PubMed ID: 26335719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veterinary vaccines against Toxoplasma gondii.
    Innes EA; Bartley PM; Maley S; Katzer F; Buxton D
    Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):246-51. PubMed ID: 19430650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of host autophagy machinery in controlling
    Besteiro S
    Virulence; 2019 Dec; 10(1):438-447. PubMed ID: 30269643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
    Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
    Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?
    Webster JP; Kaushik M; Bristow GC; McConkey GA
    J Exp Biol; 2013 Jan; 216(Pt 1):99-112. PubMed ID: 23225872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of innate immunity by Toxoplasma gondii virulence effectors.
    Hunter CA; Sibley LD
    Nat Rev Microbiol; 2012 Nov; 10(11):766-78. PubMed ID: 23070557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of Immune Responses Elicited by Adjuvanted Tachyzoite Lysate Vaccines Developed from Two Different Toxoplasma gondii Strains Isolated in Turkey].
    Polat C; Gülçe İz S; Döşkaya M; Can H; Caner A; Değirmenci A; Balcan E; Gürüz Y
    Mikrobiyol Bul; 2013 Jan; 47(1):122-34. PubMed ID: 23390909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response and immunopathology during toxoplasmosis.
    Dupont CD; Christian DA; Hunter CA
    Semin Immunopathol; 2012 Nov; 34(6):793-813. PubMed ID: 22955326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in imaging the innate and adaptive immune response to Toxoplasma gondii.
    John B; Weninger W; Hunter CA
    Future Microbiol; 2010 Sep; 5(9):1321-8. PubMed ID: 20860479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogeny and immunological control of toxoplasmosis.
    Derouin F
    Braz J Med Biol Res; 1992; 25(12):1163-9. PubMed ID: 1341911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii infection and behaviour - location, location, location?
    McConkey GA; Martin HL; Bristow GC; Webster JP
    J Exp Biol; 2013 Jan; 216(Pt 1):113-9. PubMed ID: 23225873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites.
    Welter A; Mineo JR; de Oliveira Silva DA; Lourenço EV; Vieira Ferro EA; Roque-Barreira MC; Maria da Silva N
    Int J Exp Pathol; 2007 Oct; 88(5):325-35. PubMed ID: 17877534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Ihara F; Fereig RM; Himori Y; Kameyama K; Umeda K; Tanaka S; Ikeda R; Yamamoto M; Nishikawa Y
    Front Immunol; 2020; 11():1709. PubMed ID: 32849602
    [No Abstract]   [Full Text] [Related]  

  • 20. The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.
    Fox BA; Rommereim LM; Guevara RB; Falla A; Hortua Triana MA; Sun Y; Bzik DJ
    mBio; 2016 May; 7(3):. PubMed ID: 27165797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.